NXTM stock: buy or sell?

NXTM stock price: $30.00 0.00% At close on June 28th, 2019

Updated on:
June 28th, 2019


After several days of continuous hikes in past weeks, NxStage Medical stayed steady 0.00% to $30.00. With June, it's been 5 climbing sessions in a row, soaring $0.83 or 2.85%.

NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure.

Should I buy NXTM stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

These 2 buy setups are elegible for NxStage Medical stock right now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is NxStage Medical stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for NXTM stock for the last month.

NXTM stock analysis

Daily outlook

NxStage Medical shares touched new all time highs again on June, marking to $30.00. Shares closed at $30.00 and stayed steady 0.00%.

After reaching all time highs on June, NxStage Medical stayed constant 0.00% on June to $30.00. Since price and SMA100d lines crossed up on January, NXTM climbed $1.72 (6.08%).

NXTM stock chart (daily)

Weekly outlook

NxStage Medical shares topped new all time highs again this week, setting highs to $30.00. Shares closed at $30.00 and stayed steady 0.00% during the week. Late June was the fifth green week in a row.

Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $29.26 resistance. Since price and SMA20w lines crossed up late January, NXTM climbed $1.56 (5.49%).

NXTM stock chart (weekly)

NXTM stock price history

NXTM IPO was on January 4th, 2018 at $24.56 per share1. Since then, NXTM stock surged a 22.10%, with a yearly average of 22.10%. If you had invested $1,000 in NXTM stock in 2018, it would worth $221.00 today.

1: Adjusted price after possible price splits or reverse-splits.

NXTM stock historical price chart

NXTM stock reached all-time highs on June with a price of $30.00.

NXTM stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' NXTM stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price forecast for NxStage Medical stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since February, when NxStage Medical posted its last earnings report, it remained steady a tight 0.00%. Unfortunately, reported EPS is not yet available in our database.
NXTM earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2017, NxStage Medical annual turnover escalated an excellent 7.52% to $393.94 M USD from $366.38 marked in 2016. Instead, its income margin (compared to revenues) declined to -3.55%, that is $-13.99 million.

To have an updated picture of the financial situation of NxStage Medical, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q4 that can be compared to 2017 fiscal year results. Annual NxStage Medical TTM sales up to December 2018 were $322.39 and earnings were $-3.17 million USD. If we compare this TTM figures with the last reported annuality, we can esteem NxStage Medical business evolution since December 2017: Annual turnover up to December, compared to lastest yearly report, plunged a dreadful -18.16%. However, profit margin (net income/revenues) stepped up at -3.55%.

NXTM annual Sales and Income evolution
2013$263 M-$-18.56 M-7.0%-
2014$302 M14.45%$-23.95 M-7.9%29.02%
2015$336 M11.48%$-15.34 M-4.6%-35.93%
2016$366 M9.00%$-4.77 M-1.3%-68.90%
2017$394 M7.52%$-13.99 M-3.6%193.27%
TTM $322 M-18.16%$-3.17 M-1.0%-77.37%

Quarterly financial results

NxStage Medical posted M in revenues for 2018-Q4, a -100.00% less compared to previous quarter. Reported quarter income marked M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was 0.81%. When comparing revenues to same quarter last year, NxStage Medical sales marked a chilling drop down and plummed a -100.00%.
NXTM quarterly Sales and Income evolution
2016-Q4$93 M-$-1.60 M-1.7%-
2017-Q1$97 M4.11%$-1.19 M-1.2%-25.63%
2017-Q2$96 M-0.63%$-2.09 M-2.2%75.63%
2017-Q3$97 M1.12%$-8.45 M-8.7%304.07%
2017-Q4$104 M6.48%$-2.27 M-2.2%-73.13%
2018-Q1$107 M3.57%$-1.46 M-1.4%-35.70%
2018-Q2$107 M-0.31%$-2.59 M-2.4%77.45%
2018-Q3$108 M1.08%$0.88 M0.8%-134.03%

NxStage Medical ownership

When you are planning to invest in shares of a stock, it's worth to review its ownership structure.

NxStage Medical shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a of all shares.

For a better understanding, the next table shows ownership data compared to other related stocks:

Market cap$0.0 M
Total shares0.0 M
Float shares0.0 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

NXTM summary

Friday, June 28th, 2019
Day range$29.98 - $30.00
Previous close$30.00
Session gain0.00%
Average true range$0.17
50d mov avg$28.84
100d mov avg$28.59
200d mov avg$28.23
Daily pattern
Weekly pattern lb02c

NxStage Medical performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We compared NxStage Medical against in the following table:
NXTMNxStage Medical6.23%5.86%22.50%

NxStage Medical competitors

Unfortunately, we could not find any public company that could be defined as NxStage Medical competitor. This doesn't mean NxStage Medical does not have any competitor in the market, it's just we could not detected it.